2 Patents
- US117521392023Therapeutic Combinations of Orally Administered Irinotecan and a P-gp Inhibitor for the Treatment of Cancer
Athenex HK Innovative Limited
0 cites - US117521562023Compositions and Methods for Treating Hyperproliferative Skin Disorders
Athenex HK Innovative Limited
0 cites